Cargando…
Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We rep...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608398/ https://www.ncbi.nlm.nih.gov/pubmed/37853866 http://dx.doi.org/10.5021/ad.21.074 |
_version_ | 1785127770985070592 |
---|---|
author | Choi, Yeon-Gu Park, Hyeon Jeong Yim, Sunmin Lee, Heun Joo Choi, Young Jun Kim, Won-Serk Lee, Ga-Young |
author_facet | Choi, Yeon-Gu Park, Hyeon Jeong Yim, Sunmin Lee, Heun Joo Choi, Young Jun Kim, Won-Serk Lee, Ga-Young |
author_sort | Choi, Yeon-Gu |
collection | PubMed |
description | Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class. |
format | Online Article Text |
id | pubmed-10608398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-106083982023-10-28 Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir Choi, Yeon-Gu Park, Hyeon Jeong Yim, Sunmin Lee, Heun Joo Choi, Young Jun Kim, Won-Serk Lee, Ga-Young Ann Dermatol Case Report Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023-05 2023-05-15 /pmc/articles/PMC10608398/ /pubmed/37853866 http://dx.doi.org/10.5021/ad.21.074 Text en Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Choi, Yeon-Gu Park, Hyeon Jeong Yim, Sunmin Lee, Heun Joo Choi, Young Jun Kim, Won-Serk Lee, Ga-Young Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title | Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title_full | Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title_fullStr | Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title_full_unstemmed | Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title_short | Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir |
title_sort | fixed drug eruption in a patient taking valacyclovir without cross-reactivity to acyclovir |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608398/ https://www.ncbi.nlm.nih.gov/pubmed/37853866 http://dx.doi.org/10.5021/ad.21.074 |
work_keys_str_mv | AT choiyeongu fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT parkhyeonjeong fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT yimsunmin fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT leeheunjoo fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT choiyoungjun fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT kimwonserk fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir AT leegayoung fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir |